Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.3449
+0.0201 (6.19%)
At close: Dec 18, 2025
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of $37.13 million as of December 26, 2025. Its market cap has increased by 206.75% in one year.
Market Cap
37.13M
Enterprise Value
36.59M
Revenue
88.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.34
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 35.57M to 37.13M, an increase of 4.38%. That is a compound annual growth rate of 0.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 37.13M | 261.19% |
| Dec 30, 2024 | 10.28M | -24.05% |
| Dec 29, 2023 | 13.53M | 27.76% |
| Dec 30, 2022 | 10.59M | -28.16% |
| Dec 30, 2021 | 14.74M | 116.26% |
| Dec 30, 2020 | 6.82M | -49.96% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |